Newsroom | 42332 results

MADISON, Wis.--(BUSINESS WIRE)--Navitus, the nation’s first and largest transparent, pass-through pharmacy benefit manager (PBM), today announced the expanded implementation of Banjo Health. Banjo is an advanced automation platform with artificial intelligence (AI) capabilities designed to modernize and simplify prior authorization workflows that are central to pharmacy benefits management. Now implemented across employer and health plan lines of business, including Medicare and Medicaid, these...

IRVINE, Calif.--(BUSINESS WIRE)--RIS Rx, a healthcare technology company offering gross-to-net (GTN) revenue protection and saving more than $1 billion for the world’s leading pharmaceutical manufacturers, today announced the appointment of Stuart McGuigan to its Board of Directors. Mr. McGuigan is an expert technology and healthcare executive with more than three decades of experience driving digital transformation and operational excellence in complex global organizations. Most recently, he s...

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   1. Details of the person discharg...

PITTSBURGH--(BUSINESS WIRE)--Biocerta Precision Diagnostics, Inc., a biotechnology company pioneering functional drug sensitivity testing (DST) to personalize cancer therapy, today announced two major business milestones: (1) an exclusive licensing agreement with the University of Miami covering core intellectual property assets which contribute to Biocerta’s DST technology, and (2) a strategic development and commercialization agreement with Acumen Partners to support the Company through early...

SAN FRANCISCO--(BUSINESS WIRE)--Salesforce (NYSE: CRM), the world’s #1 AI CRM, announced today that Novartis (NYSE: NVS), a leading global innovative medicines company, has selected Salesforce’s Agentforce Life Sciences for Customer Engagement to connect patient and healthcare professional (HCP) experiences, enabling teams to focus on strategic and meaningful customer interactions. Building upon its existing investments with Agentforce Health, Data 360 for Health & Life Sciences, MuleSoft f...

LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. for the past 44 years, today announced the publication of its new report, “Strengthening Belonging for Underserved Boys.” The report explores how loneliness has become a pressing public health issue among boys, particularly those from racially and ethnically diverse backgrounds, rural communities, LGBTQ+ identities, and boys with differing physical and mental abilities. According to a Gallup poll, 25%...

WENDELSHEIM, Germany--(BUSINESS WIRE)--MODAG GmbH announced it has received a $1 million research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). This funding is part of MJFF’s strategic research agenda focused on supporting objective tools to biologically measure and track the progression of Parkinson’s disease (PD) to improve clinical trial design. The Foundation will support continued advancement of MODAG's innovative PET tracer programs, which enable earlier and mo...

GALWAY, Ireland--(BUSINESS WIRE)--AVeta Medical, developer of the VITA AV™ platform, today announced the appointment of Karen Noblett, M.D. as CEO. Eileen Duffy, who served as interim CEO, has been appointed Chair of the Board of Directors. “Karen’s deep experience leading clinical programs, guiding regulatory strategy, and scaling med-tech innovation aligns directly with AVeta’s next phase of growth,” said Eileen Duffy, incoming Chair of AVeta’s Board of Directors. A nationally recognized lead...

SAN FRANCISCO--(BUSINESS WIRE)--SleepRes, Inc. has received U.S. FDA 510(k) clearance for the Kricket PAP device, powered by KPAP™....

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming J.P. Morgan 44th Annual Healthcare Conference. AtriCure’s management is scheduled to present on Wednesday, January 14, 2026, at 10:30 a.m. Pacific Standard Time. Interested parties may access a live aud...